The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.

Chen, Gege

The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells. [electronic resource] - Oncology reports Jul 2017 - 488-496 p. digital

Publication Type: Journal Article

1791-2431

10.3892/or.2017.5675 doi


Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Blueberry Plants--chemistry
Bortezomib--pharmacology
Caspases--metabolism
Cell Line, Tumor
Cell Proliferation--drug effects
DNA Damage--drug effects
Drug Resistance, Neoplasm
Drug Synergism
Histone Deacetylase Inhibitors--pharmacology
Humans
Hydroxamic Acids--pharmacology
Indoles--pharmacology
MAP Kinase Signaling System--drug effects
Membrane Potential, Mitochondrial--drug effects
Multiple Myeloma--drug therapy
Neoplasm Recurrence, Local--drug therapy
Panobinostat
S Phase Cell Cycle Checkpoints--drug effects
Stilbenes--pharmacology
Vorinostat
p38 Mitogen-Activated Protein Kinases--metabolism